American Shared Hospital Services ROE 2010-2025 | AMS
Current and historical return on equity (ROE) values for American Shared Hospital Services (AMS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| American Shared Hospital Services ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.00B | $0.03B | 6.50% |
| 2024-12-31 | $0.00B | $0.03B | 10.00% |
| 2024-09-30 | $0.00B | $0.03B | 13.79% |
| 2024-06-30 | $0.00B | $0.03B | 14.55% |
| 2024-03-31 | $0.00B | $0.03B | 0.00% |
| 2023-12-31 | $0.00B | $0.03B | 0.00% |
| 2023-09-30 | $0.00B | $0.03B | 0.00% |
| 2023-06-30 | $0.00B | $0.03B | 0.00% |
| 2023-03-31 | $0.00B | $0.03B | 0.00% |
| 2022-12-31 | $0.00B | $0.03B | 0.00% |
| 2022-09-30 | $0.00B | $0.03B | 0.00% |
| 2022-06-30 | $0.00B | $0.03B | 0.00% |
| 2022-03-31 | $0.00B | $0.03B | 0.00% |
| 2021-12-31 | $0.00B | $0.02B | 0.00% |
| 2021-09-30 | $-0.01B | $0.02B | -25.00% |
| 2021-06-30 | $-0.01B | $0.02B | -23.30% |
| 2021-03-31 | $-0.01B | $0.02B | -21.82% |
| 2020-12-31 | $-0.01B | $0.02B | -20.51% |
| 2020-09-30 | $0.00B | $0.03B | 0.00% |
| 2020-06-30 | $0.00B | $0.03B | 0.00% |
| 2020-03-31 | $0.00B | $0.03B | 0.00% |
| 2019-12-31 | $0.00B | $0.03B | 0.00% |
| 2019-09-30 | $0.00B | $0.03B | 0.00% |
| 2019-06-30 | $0.00B | $0.03B | 0.00% |
| 2019-03-31 | $0.00B | $0.03B | 0.00% |
| 2018-12-31 | $0.00B | $0.03B | 0.00% |
| 2018-09-30 | $0.00B | $0.03B | 3.25% |
| 2018-06-30 | $0.00B | $0.03B | 3.33% |
| 2018-03-31 | $0.00B | $0.03B | 3.42% |
| 2017-12-31 | $0.00B | $0.03B | 3.51% |
| 2017-09-30 | $0.00B | $0.03B | 0.00% |
| 2017-06-30 | $0.00B | $0.03B | 0.00% |
| 2017-03-31 | $0.00B | $0.03B | 0.00% |
| 2016-12-31 | $0.00B | $0.03B | 0.00% |
| 2016-09-30 | $0.00B | $0.03B | 0.00% |
| 2016-06-30 | $0.00B | $0.03B | 0.00% |
| 2016-03-31 | $0.00B | $0.03B | -8.00% |
| 2015-12-31 | $0.00B | $0.03B | -7.92% |
| 2015-09-30 | $0.00B | $0.03B | -7.84% |
| 2015-06-30 | $0.00B | $0.03B | -7.84% |
| 2015-03-31 | $0.00B | $0.03B | -3.92% |
| 2014-12-31 | $0.00B | $0.03B | -4.00% |
| 2014-09-30 | $0.00B | $0.03B | -4.08% |
| 2014-06-30 | $0.00B | $0.03B | -4.12% |
| 2014-03-31 | $0.00B | $0.02B | 0.00% |
| 2013-12-31 | $0.00B | $0.02B | 0.00% |
| 2013-09-30 | $0.00B | $0.02B | 0.00% |
| 2013-06-30 | $0.00B | $0.03B | 0.00% |
| 2013-03-31 | $0.00B | $0.03B | 0.00% |
| 2012-12-31 | $0.00B | $0.03B | 0.00% |
| 2012-09-30 | $0.00B | $0.03B | 0.00% |
| 2012-06-30 | $0.00B | $0.03B | 0.00% |
| 2012-03-31 | $0.00B | $0.03B | 0.00% |
| 2011-12-31 | $0.00B | $0.03B | 0.00% |
| 2011-09-30 | $0.00B | $0.02B | 0.00% |
| 2011-06-30 | $0.00B | $0.02B | 0.00% |
| 2011-03-31 | $0.00B | $0.02B | 0.00% |
| 2010-12-31 | $0.00B | $0.02B | 0.00% |
| 2010-09-30 | $0.00B | $0.02B | 0.00% |
| 2010-06-30 | $0.00B | $0.02B | 0.00% |
| 2010-03-31 | $0.00B | $0.02B | 0.00% |
| 2009-12-31 | $0.00B | $0.02B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.015B | $0.028B |
| American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery services, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia . The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the twenty first Century concept. Through its equity investment in Still River Systems, AMS also plans to complement these services with the Clinatron-two hundred fifty, proton beam radiation therapy system, which has not yet been approved by the FDA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.503B | 85.19 |
| Thermo Fisher Scientific (TMO) | United States | $151.179B | 18.29 |
| Edwards Lifesciences (EW) | United States | $43.872B | 28.76 |
| Alcon (ALC) | Switzerland | $42.488B | 28.71 |
| IDEXX Laboratories (IDXX) | United States | $40.599B | 46.66 |
| DexCom (DXCM) | United States | $33.262B | 51.41 |
| STERIS (STE) | Ireland | $23.954B | 26.41 |
| IQVIA Holdings (IQV) | United States | $23.881B | 13.38 |
| Mettler-Toledo (MTD) | United States | $23.609B | 28.08 |
| Waters (WAT) | United States | $20.737B | 29.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.307B | 0.00 |
| Hologic (HOLX) | United States | $12.141B | 13.19 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $10.330B | 81.08 |
| Masimo (MASI) | United States | $8.128B | 29.98 |
| Globus Medical (GMED) | United States | $7.933B | 18.90 |
| Glaukos (GKOS) | United States | $5.553B | 0.00 |
| Teleflex (TFX) | United States | $5.344B | 8.82 |
| TransMedics (TMDX) | United States | $4.172B | 90.69 |
| Integer Holdings (ITGR) | United States | $4.123B | 21.60 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Veracyte (VCYT) | United States | $2.146B | 30.11 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.990B | 17.89 |
| Alphatec Holdings (ATEC) | United States | $1.824B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.375B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.84 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.672B | 0.00 |
| IRadimed (IRMD) | United States | $0.665B | 33.73 |
| RxSight (RXST) | United States | $0.646B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.603B | 13.19 |
| NeuroPace (NPCE) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.98 |
| Delcath Systems (DCTH) | United States | $0.562B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.501B | 13.33 |
| AxoGen (AXGN) | United States | $0.498B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.283B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| 908 Devices (MASS) | United States | $0.170B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.116B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.80 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.054B | 16.45 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.041B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.75 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |